Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 20, 2014
|
| In: |
The New England journal of medicine
Year: 2014, Jahrgang: 370, Heft: 8, Pages: 709-722 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1308345 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1056/NEJMoa1308345
|
| Verfasserangaben: | Olivier L. Chinot, M.D., Wolfgang Wick, M.D., Warren Mason, M.D., Roger Henriksson, M.D., Frank Saran, M.D., Ryo Nishikawa, M.D., Antoine F. Carpentier, M.D., Ph.D., Khe Hoang-Xuan, M.D., Ph.D., Petr Kavan, M.D., Ph.D., Dana Cernea, Ph.D., Alba A. Brandes, M.D., Magalie Hilton, M.Sc., Lauren Abrey, M.D., and Timothy Cloughesy, M.D. |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1526172356 | ||
| 003 | DE-627 | ||
| 005 | 20230426105821.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160223s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMoa1308345 |2 doi | |
| 035 | |a (DE-627)1526172356 | ||
| 035 | |a (DE-576)456172351 | ||
| 035 | |a (DE-599)BSZ456172351 | ||
| 035 | |a (OCoLC)1340900591 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Chinot, Olivier L. |e VerfasserIn |0 (DE-588)1084035049 |0 (DE-627)848243048 |0 (DE-576)456172289 |4 aut | |
| 245 | 1 | 0 | |a Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma |c Olivier L. Chinot, M.D., Wolfgang Wick, M.D., Warren Mason, M.D., Roger Henriksson, M.D., Frank Saran, M.D., Ryo Nishikawa, M.D., Antoine F. Carpentier, M.D., Ph.D., Khe Hoang-Xuan, M.D., Ph.D., Petr Kavan, M.D., Ph.D., Dana Cernea, Ph.D., Alba A. Brandes, M.D., Magalie Hilton, M.Sc., Lauren Abrey, M.D., and Timothy Cloughesy, M.D. |
| 264 | 1 | |c February 20, 2014 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.02.2016 | ||
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 370(2014), 8, Seite 709-722 |h Online-Ressource |w (DE-627)266889484 |w (DE-600)1468837-2 |w (DE-576)075962454 |x 1533-4406 |7 nnas |a Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma |
| 773 | 1 | 8 | |g volume:370 |g year:2014 |g number:8 |g pages:709-722 |g extent:14 |a Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMoa1308345 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160223 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 2 | ||
| 999 | |a KXP-PPN1526172356 |e 2899700243 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"14 S."}],"title":[{"title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","title_sort":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma"}],"language":["eng"],"name":{"displayForm":["Olivier L. Chinot, M.D., Wolfgang Wick, M.D., Warren Mason, M.D., Roger Henriksson, M.D., Frank Saran, M.D., Ryo Nishikawa, M.D., Antoine F. Carpentier, M.D., Ph.D., Khe Hoang-Xuan, M.D., Ph.D., Petr Kavan, M.D., Ph.D., Dana Cernea, Ph.D., Alba A. Brandes, M.D., Magalie Hilton, M.Sc., Lauren Abrey, M.D., and Timothy Cloughesy, M.D."]},"note":["Gesehen am 23.02.2016"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Olivier L.","role":"aut","family":"Chinot","display":"Chinot, Olivier L."},{"family":"Wick","display":"Wick, Wolfgang","role":"aut","given":"Wolfgang"}],"relHost":[{"id":{"eki":["266889484"],"zdb":["1468837-2"],"issn":["1533-4406"]},"origin":[{"dateIssuedKey":"1928","dateIssuedDisp":"1928-","publisherPlace":"Waltham, Mass. ; Boston, Mass.","publisher":"MMS ; MMS"}],"name":{"displayForm":["Massachusetts Medical Society"]},"note":["Gesehen am 04.08.25"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"NEJM","title":"The New England journal of medicine","title_sort":"New England journal of medicine"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"NEJM"}],"recId":"266889484","part":{"volume":"370","pages":"709-722","extent":"14","year":"2014","issue":"8","text":"370(2014), 8, Seite 709-722"},"disp":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastomaThe New England journal of medicine","corporate":[{"display":"Massachusetts Medical Society","role":"isb"}],"pubHistory":["198.1928 -"]}],"recId":"1526172356","id":{"doi":["10.1056/NEJMoa1308345"],"eki":["1526172356"]},"origin":[{"dateIssuedDisp":"February 20, 2014","dateIssuedKey":"2014"}]} | ||
| SRT | |a CHINOTOLIVBEVACIZUMA2020 | ||